miRNA target identification based on the binding of miR-136-5p and miR-501-3p seed sequence to the respective target genes confirmed their role in regulating FCGR gene expression in patients with MAS, when MAS patient gene expression data were concatenated for target analysis. This evidence concerns the gene FCGR2A and macrophage activation syndrome.